PE20212322A1 - Vacuna de influenza atenuada en vivo composicion y proceso de preparacion de los mismos - Google Patents

Vacuna de influenza atenuada en vivo composicion y proceso de preparacion de los mismos

Info

Publication number
PE20212322A1
PE20212322A1 PE2021001342A PE2021001342A PE20212322A1 PE 20212322 A1 PE20212322 A1 PE 20212322A1 PE 2021001342 A PE2021001342 A PE 2021001342A PE 2021001342 A PE2021001342 A PE 2021001342A PE 20212322 A1 PE20212322 A1 PE 20212322A1
Authority
PE
Peru
Prior art keywords
influenza
influenza virus
live attenuated
preparation process
vaccine composition
Prior art date
Application number
PE2021001342A
Other languages
English (en)
Inventor
Rajeev Mhalasakant Dhere
Leena Ravindra Yeolekar
Milan Shomenath Ganguly
Parikshit Dharampal Tyagi
Umesh Gorakh Sagar
Swapnil Prabhakar Narale
Yashodhan Dilip Anaspure
Sham Ramdas Tupe
Original Assignee
Serum Inst Of India Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serum Inst Of India Pvt Ltd filed Critical Serum Inst Of India Pvt Ltd
Publication of PE20212322A1 publication Critical patent/PE20212322A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Referido a una composicion inmunogenica que comprende: a) Uno o mas virus de la influenza; b) Uno o mas carbohidratos; c) Uno o mas de acido amino; y d) Gelatina. En donde el virus de la influenza comprende un virus de influenza pandemica o estacional, un virus de vacuna viva atenuada contra la influenza (LAIV), un virus de influenza inactivado, un virus de influenza quimerico o un virus de influenza recombinante; en la que la composicion es monovalente en terminos del virus de la influenza derivado de la influenza tipo A o tipo B o tipo C o sus subtipos. Tambien se refiere a un metodo para preparar dicha composicion inmunogenica.
PE2021001342A 2019-02-15 2020-02-07 Vacuna de influenza atenuada en vivo composicion y proceso de preparacion de los mismos PE20212322A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201921006071 2019-02-15
PCT/IN2020/050121 WO2020165912A1 (en) 2019-02-15 2020-02-07 Live attenuated influenza vaccine composition and process for preparation thereof

Publications (1)

Publication Number Publication Date
PE20212322A1 true PE20212322A1 (es) 2021-12-14

Family

ID=69740470

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2021001342A PE20212322A1 (es) 2019-02-15 2020-02-07 Vacuna de influenza atenuada en vivo composicion y proceso de preparacion de los mismos

Country Status (20)

Country Link
US (1) US20220211837A1 (es)
EP (1) EP3924052A1 (es)
JP (1) JP2022520443A (es)
KR (1) KR20210129073A (es)
CN (1) CN113646047A (es)
AR (1) AR119691A1 (es)
AU (1) AU2020222113A1 (es)
BR (1) BR112021016059A2 (es)
CA (1) CA3130036A1 (es)
CL (1) CL2021002111A1 (es)
CO (1) CO2021010751A2 (es)
IL (1) IL285526A (es)
JO (1) JOP20200037A1 (es)
MA (1) MA54942A (es)
MX (1) MX2021009837A (es)
PE (1) PE20212322A1 (es)
SG (1) SG11202108766RA (es)
TW (1) TW202045205A (es)
UY (1) UY38587A (es)
WO (1) WO2020165912A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0202846A3 (en) * 1999-09-24 2003-12-29 Smithkline Beecham Biolog Intranasal influenza virus vaccine
CA2517181C (en) * 2003-02-25 2013-07-16 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
ES2633471T3 (es) * 2004-10-06 2017-09-21 Medimmune, Llc Composiciones de vacuna contra la gripe estables a temperatura de refrigerador
RU2015103990A (ru) * 2008-09-24 2015-10-27 Медиммун, Ллк Способы культивирования клеток, размножения и очистки вирусов
CA2993242C (en) * 2010-04-15 2020-12-15 Shin Nippon Biomedical Laboratories, Ltd. Methods and compositions for intranasal delivery
TWI670085B (zh) * 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
WO2017047089A1 (en) * 2015-09-16 2017-03-23 Shin Nippon Biomedical Laboratories, Ltd. Vaccine compositions
CA3069444A1 (en) * 2017-07-11 2019-01-17 Universal Stabilization Technologies, Inc. Method for preserving biopharmaceuticals

Also Published As

Publication number Publication date
MA54942A (fr) 2021-12-22
BR112021016059A2 (pt) 2021-10-13
KR20210129073A (ko) 2021-10-27
AR119691A1 (es) 2022-01-05
SG11202108766RA (en) 2021-09-29
CA3130036A1 (en) 2020-08-20
JOP20200037A1 (ar) 2020-08-15
US20220211837A1 (en) 2022-07-07
CO2021010751A2 (es) 2021-09-09
EP3924052A1 (en) 2021-12-22
CN113646047A (zh) 2021-11-12
CL2021002111A1 (es) 2022-01-28
TW202045205A (zh) 2020-12-16
MX2021009837A (es) 2021-09-10
IL285526A (en) 2021-09-30
AU2020222113A1 (en) 2021-10-07
UY38587A (es) 2020-09-30
JP2022520443A (ja) 2022-03-30
WO2020165912A1 (en) 2020-08-20

Similar Documents

Publication Publication Date Title
BR112018013387A2 (pt) vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit
PE20201443A1 (es) Una composicion inmunogenica que tiene estabilidad mejorada, inmunogeneicidad potenciada y reactogenicidad reducida y proceso para la preparacion de la misma
CL2019000704A1 (es) Vectores de adenovirus canino.
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
CO2018010874A2 (es) Vacuna de virus de zika atenuado vivo
BR112018076234A2 (pt) vacina contra o vírus da bronquite infecciosa
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
BR112017002496A2 (pt) agente de controle contra a síndrome reprodutiva e respiratória porcina
CL2021003211A1 (es) Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018)
CO2023015036A2 (es) Composición inmunogénica contra la influenza
PE20170429A1 (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9
CO2021004556A2 (es) Composición de vacuna combinada que comprende dosis reducidas del virus inactivado de la polio y método de preparación de la misma
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
AR118881A1 (es) Composiciones de virus inactivado y formulaciones de vacuna contra el zika
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
BR112018000037A2 (pt) partículas semelhantes a vírus recombinantes usando a proteína gag do vírus da imunodeficiência bovina (vlp de bgag), vacina, vetor plasmidial de transferência para produzir a vlp de bgag, método para fazer a vlp de bgag, método para preparar a vacina
BR112013017939A2 (pt) composição imunogênica liofilizada termoestável, método de preparação de uma composição compreendendo um antígeno viral atenuado e vesículas e usos da composição ou formulação
PE20212322A1 (es) Vacuna de influenza atenuada en vivo composicion y proceso de preparacion de los mismos
EP4378474A3 (en) Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof
JP2018501258A5 (es)
CL2020002876A1 (es) Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420)
CL2023002187A1 (es) Virus para vacuna contra el síndrome respiratorio y reproductivo porcino
BR112020010202A8 (pt) Cepa para vacina de influenza aviária h9 que diferencia animais infectados de vacinados, e método de preparação para a mesma